Skip to main content
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2005 Jan;20(1):56–60. doi: 10.1007/BF02893043

Picrotoxin-induced convulsions and lysosomal function in the rat brain

Munjal M Acharya 1,, Surbhi H Khamesra 1, Surendra S Katyare 1
PMCID: PMC3454155  PMID: 23105495

Abstract

The effect of picrotoxin-induced convulsions on lysosomal function in rat brain were evaluated by measuring the free as well as total acid phosphatase, cathepsin D, acid ribonuclease (RNAse II) and acid deoxyribonuclease (DNAse II) activities. Following picrotoxin treatment the free RNAse II activity increased whereas the total activities of practically all the other enzymes decreased. Paradoxically, the cathepsin D activity, free as well the total was completely abolished. In case of all the enzymes the ratio of Total activity/Free activity decreased indicating increased lysosomal membrane fragility which could lead to process of neurodegeneration in the epileptic animals.

Keywords: Picrotoxin, Convulsions, Epilepsy, Lysosomal function, Lysosomal enzymes

Full Text

The Full Text of this article is available as a PDF (382.3 KB).

References

  • 1.Sloviter R.S. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann. Neurol. 1994;35:640–654. doi: 10.1002/ana.410350604. [DOI] [PubMed] [Google Scholar]
  • 2.Zola-Morgan S., Squire L. R., Amaral D. G. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J. Neurosci. 1986;6:2950–2967. doi: 10.1523/JNEUROSCI.06-10-02950.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zola-Morgan S., Squire L. R., Rempel N. L., Amaral D. G. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J. Neurosci. 1992;12:2582–2595. doi: 10.1523/JNEUROSCI.12-07-02582.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Singh R. Lysosomal acid phosphatase hyperactivity in cobalt epilepsy. Ind. J. Exp. Biol. 1980;18:716–719. [PubMed] [Google Scholar]
  • 5.Sangiorgi S., Ferlini A., Zanetti A., Mochi M. Reduced activity of arylsulfatase A and predisposition to neurological disorders: analysis of 140 pediatric patients. Am. J. Med. Genet. 1991;40:365–369. doi: 10.1002/ajmg.1320400324. [DOI] [PubMed] [Google Scholar]
  • 6.Tinuper P., Plazzi G., Monari L., Sangiorgi S., Pellissier J. F., Cerullo A., Provini F., Capellari S., Baruzzi A., Lugaresi E. Arylsulfatase A pseudodeficiency and Lafora bodies in a patient with progressive myoclonic epilepsy. Epilepsia. 1994;35:332–335. doi: 10.1111/j.1528-1157.1994.tb02440.x. [DOI] [PubMed] [Google Scholar]
  • 7.Hetman M., Filipkomski R. K., Domagala W., Kaczmarck L. Elevated cathepsin D expresson in kainate-evoked rat brain neurodegeneration. Exptl. Neurol. 1995;136:53–63. doi: 10.1006/exnr.1995.1083. [DOI] [PubMed] [Google Scholar]
  • 8.Houseweart M. K., Pennacchio L. A., Vilaythong A., Peters C., Noebels J. L., Myers R. M. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1) J Neurobiol. 2003;56(4):315–327. doi: 10.1002/neu.10253. [DOI] [PubMed] [Google Scholar]
  • 9.Rinne R., Saukko P., Jarvinen M., Lehesjoki A. E. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann Med. 2002;34(5):380–385. doi: 10.1080/078538902320772124. [DOI] [PubMed] [Google Scholar]
  • 10.Mazarati A. M., Halaszi E., Telegdy G. Anticonvulsant effects of galanin administrated into the central nervous system upon the picrotoxin-induced seizures syndrome in rats. Brain Res. 1992;589:164–166. doi: 10.1016/0006-8993(92)91179-I. [DOI] [PubMed] [Google Scholar]
  • 11.Kubova M., Bohuslav T., Mares P. Effects of clonazepam on picrotoxin induced convulsions. Physiol. Res. 1992;41:167–169. [PubMed] [Google Scholar]
  • 12.Khandkar M. A., Parmar D. V., Das M., Katyare S. S. Is activation of lysosomal enzymes responsible for paracetamol-induced hepatotoxicity and nephrotoxicity? J. Pharm. Pharmacol. 1996;48:437–440. doi: 10.1111/j.2042-7158.1996.tb05948.x. [DOI] [PubMed] [Google Scholar]
  • 13.Fiske C. H., Subba Row Y. Colorimetric detemination of phosphorous. J Biol Chem. 1925;66:375–375. [Google Scholar]
  • 14.Nerurkar M. A., Satav J. G., Katyare S. S. Insulin dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia. 1988;31:119–122. doi: 10.1007/BF00395559. [DOI] [PubMed] [Google Scholar]
  • 15.Barret A. J., Heath M. F. Lysosomal enzymes. In: Dingle J. T., editor. Lysosomes. A Laboratory handbook. Amsterdam: North Holland; 1977. pp. 19–145. [Google Scholar]
  • 16.Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951;193:265–275. [PubMed] [Google Scholar]
  • 17.Koike M., Nakanishi H., Saftig P., Ezaki J., Isahara K., Ohsawa Y., Schulz-Schaeffer W., Watanabe T., Waguri S., Kametaka S., Shibata M., Yamamoto K., Kominami E., Peters C., Figura K., Uchiyama Y. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuchsin in mouse CNS neurons. J. Neurosci. 2000;20:6898–6906. doi: 10.1523/JNEUROSCI.20-18-06898.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bernstein H. G., Keilhoff G., Kirschke H., Wiederanders B., Rinne A., Khudoerkov R., Dorn A. Cathepsins B and D in rat brain glia during experimentally induced neuropathological defects. An immunocytochemical approach. Biomed. Biochim. Acta. 1986;45:1461–1464. [PubMed] [Google Scholar]
  • 19.Olszewska D., Drewa T., Makarewicz R., Drewa J., Wozniak A., Maciak R. Significance of cathepsin B and D in physiologic and pathologic processes. Pol. Merkuriusz Lek. 2001;10:65–70. [PubMed] [Google Scholar]
  • 20.Rostislav K., Petr B., Frantisek C., Oldrich K. The cathepsin-D expression in the cytoinvasive stages of coccidia in intestinal mucosa of chickens, and the relevance of this proteinase for intracellular penetration and spreading of coccidian in host tissues. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 2001;145:2001–2001. doi: 10.5507/bp.2001.004. [DOI] [PubMed] [Google Scholar]
  • 21.Saftig P., Hartmann D., Lullmann-Rauch R., Wolff J., Evers M., Koster A., Hetman M., Figura K., Peters C. Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J Biol. Chem. 1997;272:18628–35. doi: 10.1074/jbc.272.30.18628. [DOI] [PubMed] [Google Scholar]
  • 22.Tyynela J., Sohar I., Sleat D. E., Gin R. M., Donnelly R. J., Baumann M., Haltia M., Lobel P. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 2000;19:2786–92. doi: 10.1093/emboj/19.12.2786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pope A., Nixon R. A. Proteases of human brain. Brain Res. Rev. 1984;14:245–278. [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES